Literature DB >> 15048110

Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

Fred S Harman1, Christopher J Nicol, Holly E Marin, Jerrold M Ward, Frank J Gonzalez, Jeffrey M Peters.   

Abstract

Peroxisome proliferator-activated receptor-delta (PPAR-delta; also known as PPAR-beta) is expressed at high levels in colon tumors, but its contribution to colon cancer is unclear. We examined the role of PPAR-delta in colon carcinogenesis using PPAR-delta-deficient (Ppard(-/-)) mice. In both the Min mutant and chemically induced mouse models, colon polyp formation was significantly greater in mice nullizygous for PPAR-delta. In contrast to previous reports suggesting that activation of PPAR-delta potentiates colon polyp formation, here we show that PPAR-delta attenuates colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048110     DOI: 10.1038/nm1026

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  91 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

2.  Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

Authors:  Xiangsheng Zuo; Min Xu; Jiang Yu; Yuanqing Wu; Micheline J Moussalli; Ganiraju C Manyam; Sun Il Lee; Shoudan Liang; Mihai Gagea; Jeffrey S Morris; Russell R Broaddus; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

Review 3.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

4.  PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis.

Authors:  Dingzhi Wang; Lingchen Fu; Jie Wei; Ying Xiong; Raymond N DuBois
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 5.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

6.  Peroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growth.

Authors:  Dingzhi Wang; Lingchen Fu; Wei Ning; Lixia Guo; Xiaofei Sun; Sudhansu K Dey; Rupesh Chaturvedi; Keith T Wilson; Raymond N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-24       Impact factor: 11.205

7.  Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.

Authors:  Jennifer M Monk; Wooki Kim; Evelyn Callaway; Harmony F Turk; Jennifer E Foreman; Jeffrey M Peters; Weimin He; Brad Weeks; Robert C Alaniz; David N McMurray; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

8.  The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.

Authors:  Teresa Coll; Emma Barroso; David Alvarez-Guardia; Lucía Serrano; Laia Salvadó; Manuel Merlos; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  PPAR Res       Date:  2010-07-27       Impact factor: 4.964

9.  The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells.

Authors:  Jordan Clark; Rania Nasrallah; Richard L Hébert
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse.

Authors:  Lee D Roberts; David G Hassall; Deborah A Winegar; John N Haselden; Andrew W Nicholls; Julian L Griffin
Journal:  Genome Med       Date:  2009-12-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.